Better Therapeutics, Inc. (BTTX) Misses Q4 EPS by 3c

Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q4 EPS of ($0.48), $0.03 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c